These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 15460847

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Mac-2-binding protein is a diagnostic marker for biliary tract carcinoma.
    Koopmann J, Thuluvath PJ, Zahurak ML, Kristiansen TZ, Pandey A, Schulick R, Argani P, Hidalgo M, Iacobelli S, Goggins M, Maitra A.
    Cancer; 2004 Oct 01; 101(7):1609-15. PubMed ID: 15378479
    [Abstract] [Full Text] [Related]

  • 3. Significance of RCAS1 antigen in hepatocellular, cholangiocellular and pancreatic carcinomas.
    Enjoji M, Nakashima M, Yamaguchi K, Kotoh K, Nakamuta M.
    J Gastroenterol Hepatol; 2005 Aug 01; 20(8):1143-8. PubMed ID: 16048560
    [Abstract] [Full Text] [Related]

  • 4. Significance of serum receptor-binding cancer antigen (RCAS1) in pancreatic cancer and benign pancreatobiliary diseases.
    Ozkan H, Akar T, Köklü S, Coban S.
    Pancreatology; 2006 Aug 01; 6(4):268-72. PubMed ID: 16636598
    [Abstract] [Full Text] [Related]

  • 5. [Evaluation of RCAS1 as serum tumor marker for pancreatic cancer].
    Yang YC, Zhao YP, Liao Q, Zhang TP, Hu Y, Dai MH.
    Zhonghua Wai Ke Za Zhi; 2009 Jul 01; 47(13):999-1001. PubMed ID: 19957811
    [Abstract] [Full Text] [Related]

  • 6. Clinical significance of serum tumour M2-PK and CA19-9 detection in the diagnosis of cholangiocarcinoma.
    Li YG, Zhang N.
    Dig Liver Dis; 2009 Aug 01; 41(8):605-8. PubMed ID: 19168405
    [Abstract] [Full Text] [Related]

  • 7. Elevated tumour marker CA19-9: clinical interpretation and influence of obstructive jaundice.
    Mann DV, Edwards R, Ho S, Lau WY, Glazer G.
    Eur J Surg Oncol; 2000 Aug 01; 26(5):474-9. PubMed ID: 11016469
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Comparative studies of DU-PAN-2, carcinoembryonic antigen, and CA19-9 in the serum and bile of patients with pancreatic and biliary tract diseases: evaluation of the influence of obstructive jaundice.
    Ohshio G, Manabe T, Watanabe Y, Endo K, Kudo H, Suzuki T, Tobe T.
    Am J Gastroenterol; 1990 Oct 01; 85(10):1370-6. PubMed ID: 2220731
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Diagnosis of biliary strictures in conjunction with endoscopic retrograde cholangiopancreaticography, with special reference to patients with primary sclerosing cholangitis.
    Lindberg B, Arnelo U, Bergquist A, Thörne A, Hjerpe A, Granqvist S, Hansson LO, Tribukait B, Persson B, Broomé U.
    Endoscopy; 2002 Nov 01; 34(11):909-16. PubMed ID: 12430077
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Are serum and biliary carcinoembryonic antigen and carbohydrate antigen19-9 determinations reliable for differentiation between benign and malignant biliary disease?
    Akdoğan M, Parlak E, Kayhan B, Balk M, Saydam G, Sahin B.
    Turk J Gastroenterol; 2003 Sep 01; 14(3):181-4. PubMed ID: 14655062
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Gallbladder bile tumor marker quantification for detection of pancreato-biliary malignancies.
    Brockmann J, Emparan C, Hernandez CA, Sulkowski U, Dietl KH, Menzel J, Wolters H, Glodny B, Senninger N.
    Anticancer Res; 2000 Sep 01; 20(6D):4941-7. PubMed ID: 11326643
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Serum cytokeratin 19 fragment (CYFRA21-1) as a prognostic factor in intrahepatic cholangiocarcinoma.
    Uenishi T, Yamazaki O, Tanaka H, Takemura S, Yamamoto T, Tanaka S, Nishiguchi S, Kubo S.
    Ann Surg Oncol; 2008 Feb 01; 15(2):583-9. PubMed ID: 17955299
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.